anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.11.21 | Diageo Overweight | Barclays Capital | |
| 17.11.21 | Diageo Buy | UBS AG | |
| 17.11.21 | Vodafone Group Buy | UBS AG | |
| 17.11.21 | Vodafone Group Buy | Deutsche Bank AG | |
| 17.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.11.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 17.11.21 | Diageo Buy | Deutsche Bank AG | |
| 17.11.21 | Diageo Hold | Kepler Cheuvreux | |
| 17.11.21 | Diageo Buy | Jefferies & Company Inc. | |
| 17.11.21 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 17.11.21 | Diageo Outperform | Credit Suisse Group | |
| 17.11.21 | Vodafone Group Outperform | Credit Suisse Group | |
| 17.11.21 | Diageo Neutral | JP Morgan Chase & Co. | |
| 17.11.21 | Diageo Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.11.21 | AstraZeneca Buy | UBS AG | |
| 17.11.21 | Diageo Buy | Goldman Sachs Group Inc. | |
| 17.11.21 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.11.21 | Diageo Neutral | JP Morgan Chase & Co. | |
| 16.11.21 | Vodafone Group Overweight | Barclays Capital | |
| 16.11.21 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 16.11.21 | Diageo Sector Perform | RBC Capital Markets | |
| 16.11.21 | Vodafone Group Outperform | Bernstein Research | |
| 15.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.11.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.11.21 | AstraZeneca Buy | UBS AG | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.11.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 10.11.21 | GSK Neutral | UBS AG | |
| 10.11.21 | Vodafone Group Buy | Jefferies & Company Inc. | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |
| 09.11.21 | BAT Buy | Jefferies & Company Inc. | |
| 08.11.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 08.11.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.11.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.11.21 | GSK Neutral | UBS AG | |
| 05.11.21 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 05.11.21 | GSK Equal Weight | Barclays Capital | |
| 05.11.21 | BP Hold | Jefferies & Company Inc. |